Organovo (ONVO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONVO vs. ORGS, TXMD, BGXX, AFMD, NERV, RLYB, RLMD, PHXM, IXHL, and GOVXShould you be buying Organovo stock or one of its competitors? The main competitors of Organovo include Orgenesis (ORGS), TherapeuticsMD (TXMD), Bright Green (BGXX), Affimed (AFMD), Minerva Neurosciences (NERV), Rallybio (RLYB), Relmada Therapeutics (RLMD), PHAXIAM Therapeutics (PHXM), Incannex Healthcare (IXHL), and GeoVax Labs (GOVX). These companies are all part of the "pharmaceutical products" industry. Organovo vs. Orgenesis TherapeuticsMD Bright Green Affimed Minerva Neurosciences Rallybio Relmada Therapeutics PHAXIAM Therapeutics Incannex Healthcare GeoVax Labs Organovo (NASDAQ:ONVO) and Orgenesis (NASDAQ:ORGS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, community ranking, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation. Do insiders & institutionals have more ownership in ONVO or ORGS? 8.2% of Organovo shares are owned by institutional investors. Comparatively, 22.6% of Orgenesis shares are owned by institutional investors. 3.7% of Organovo shares are owned by insiders. Comparatively, 5.7% of Orgenesis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has higher earnings & valuation, ONVO or ORGS? Organovo has higher earnings, but lower revenue than Orgenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganovo$122K0.00-$14.67M-$10.20N/AOrgenesis$662K16.44-$55.36MN/AN/A Does the media favor ONVO or ORGS? In the previous week, Organovo had 3 more articles in the media than Orgenesis. MarketBeat recorded 4 mentions for Organovo and 1 mentions for Orgenesis. Organovo's average media sentiment score of 0.60 beat Orgenesis' score of 0.00 indicating that Organovo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organovo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orgenesis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in ONVO or ORGS? Organovo received 195 more outperform votes than Orgenesis when rated by MarketBeat users. However, 100.00% of users gave Orgenesis an outperform vote while only 45.69% of users gave Organovo an outperform vote. CompanyUnderperformOutperformOrganovoOutperform Votes19645.69% Underperform Votes23354.31% OrgenesisOutperform Votes1100.00% Underperform VotesNo Votes Is ONVO or ORGS more profitable? Orgenesis has a net margin of -3,827.81% compared to Organovo's net margin of -10,151.64%. Orgenesis' return on equity of 0.00% beat Organovo's return on equity.Company Net Margins Return on Equity Return on Assets Organovo-10,151.64% -346.26% -187.53% Orgenesis -3,827.81%N/A -130.18% Which has more volatility & risk, ONVO or ORGS? Organovo has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Orgenesis has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. SummaryOrgenesis beats Organovo on 7 of the 12 factors compared between the two stocks. Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONVO vs. The Competition Export to ExcelMetricOrganovoBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.47M$2.96B$5.52B$7.70BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-2.4029.6122.3418.30Price / SalesN/A491.10391.19102.96Price / CashN/A168.6838.1834.62Price / BookN/A3.176.674.19Net Income-$14.67M-$72.17M$3.22B$248.05M Organovo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONVOOrganovo0.5657 of 5 starsN/AN/AN/A$3.47M$122,000.00-2.4020Gap DownORGSOrgenesisN/A$2.48+13.2%N/AN/A$11.90M$662,000.000.00150TXMDTherapeuticsMD1.526 of 5 stars$1.00-1.4%N/A-34.9%$11.53M$1.76M0.00420Analyst ForecastNews CoverageGap DownBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownAFMDAffimed3.531 of 5 stars$0.70-4.0%$13.50+1,818.2%-82.0%$11.33M$877,000.000.00200News CoverageGap DownNERVMinerva Neurosciences3.6279 of 5 stars$1.66+3.8%$5.00+201.2%-27.0%$11.19MN/A-3.779Analyst ForecastGap DownRLYBRallybio2.3768 of 5 stars$0.27+6.0%$10.00+3,672.2%-83.6%$11.03M$636,000.00-0.1740Gap DownRLMDRelmada Therapeutics4.2605 of 5 stars$0.32+11.5%$4.25+1,215.8%-92.0%$10.72MN/A-0.1110Upcoming EarningsGap DownPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049IXHLIncannex Healthcare0.6331 of 5 stars$0.59-1.7%N/A-94.0%$10.54M$98,000.00-0.423Short Interest ↑GOVXGeoVax Labs2.76 of 5 stars$0.76-8.4%$12.90+1,597.1%-30.6%$10.52M$3.95M-0.1310 Related Companies and Tools Related Companies Orgenesis Competitors TherapeuticsMD Competitors Bright Green Competitors Affimed Competitors Minerva Neurosciences Competitors Rallybio Competitors Relmada Therapeutics Competitors PHAXIAM Therapeutics Competitors Incannex Healthcare Competitors GeoVax Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONVO) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organovo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organovo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
